Zoledronate as disease modifier in osteoarthritis

DOI

Semi-annual treatment with zoledronate to reduces both cartilage degradation and pain in patients with knee osteoarthritis with active bone metabolism indicated by BML on MRI.

Identifier
DOI https://doi.org/10.34894/KBY4SC
Metadata Access https://dataverse.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.34894/KBY4SC
Provenance
Creator Mastbergen, Simon
Publisher DataverseNL
Contributor Mastbergen, Simon; dIGD datamanagers
Publication Year 2024
Rights info:eu-repo/semantics/restrictedAccess
OpenAccess false
Contact Mastbergen, Simon (umcutrecht.nl); dIGD datamanagers (umcutrecht.nl)
Representation
Resource Type Dataset
Format application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Size 442574; 81614
Version 2.1
Discipline Life Sciences; Medicine